Slide 1: Wiltrom Co., Ltd
wiittrom Your Health Partner
Slide 2: Outline
Outline Company Profile 1 2 Market Overview 3 Product Competitive Advantage 4 Strategic and Vision 2
Slide 3: Company Profile
Company Profile ◼Establish Date: 2009/12/18/ ◼Venue: Hsinchu Biomedical Science Park ◼ Capital: NTD$ 263,900,000 ◼ Product : Innovative Spinal implant ◼ President &General Manager: Dr. Huang-Chien Liang ◼ Major shareholder:INTAI TECHNOLOGY CORP. (34.11%)、 Abico Asia Capital(7.28%)、 Management team(1
Slide 4: Management Team
Management Team President&General Manager Operation Management Research and Development General Administration Ministry of Law Department, Director Department, Manager Department, Manager Department, Senior PHD. Huang-Chien Jack Su PHD. Huang-Chi Chen Jessica Hsiao Manager Liang Terry Tsai 4
Slide 5: Power of R&D Department
Power of R&D Department Material development ➢ Professional regulatory affair personnel Regulation Verification ➢ Realize regulation in each ➢ Implant materials design country ➢ Physical-Chemical Analysis ➢ Strategic plan for premarket application Product launch Mechanical design ➢ Implant design ➢
Slide 6: R&D Human Resource
R&D Human Resource Education of R&D Percentage of R&D in Wiltrom 18 personnel 26 personnel Field of R&D Total: 48 members (until 2019. 10) Develop innovative products for marketing 6
Slide 7: Quality System & Product certification schedule
Quality System & Product certification schedule Quality Management System Certification Medical Device Premarket Approval 2010/10/22 Wiltrom Spinal Fixation System Taiwan GMP Certification (Chutung Plant) 2011/03/10 2011/03/30 Wiltrom Interbody Fusion System 2011/04/01 Wiltrom Bicera Bone Graft Subs
Slide 8: License, Patent & Award
License, Patent & Award License and Patent Number of Number of Country Number of License Patent patent application Taiwan 22 18 9 China 6 4 9 USA 4 10 6 CE 1 0 4 Japan 0 0 2 Total 33 62 Award No. Time Award 1 2012 SBIR Academia-Industry Research Award 2 2014 Taiwan Innovation Award 3 2016 Bio Taipei
Slide 9: Milestone
Milestone 2009 2012 2017 2018 2019 Company Established Bone graft products Started sales in China Started sales in "Vertebral Body passed FDA 510 (k) GMP market China market Augmentation System" inspection First to develop First Taiwan spine Enters Taiwan Market patented technology private label ent
Slide 10: Outline
Outline Company Profile 1 2 Market Overview 3 Product Competitive Advantage 4 Strategic and Vision 10
Slide 11: Key Focus Market
Key Focus Market $ Million USD Vertebral Compression Bone cement Spinal Fusion Surgery Frx Surgery Liquid Liquid Powder Global Spinal Fusion Device Market Global VCF Device Market Global Bone Cement Market 2000 1200 10000 CAGR 3.4% 1000 CAGR 5.9% 8000 1500 CAGR 5.6% 9,000 800 6000 1,545 1,100 1000 6
Slide 12: Development Trend of Spinal Fixation Surgery
Development Trend of Spinal Fixation Surgery Wiltrom patented technology product Open Surgery Percutaneous spinal Single-incision spinal fixation surgery fixation surgery Incision: 10-15cm Incision: 4 x1.5cm Incision: 1.8cm Blood loss: 300-500cc Blood loss: 100-300cc Blood loss:<100cc Inpatient: 3-5
Slide 13: Wiltrom patented technology product - Single-incision spinal fixation surgery
Wiltrom patented technology product- Single- incision spinal fixation surgery TFDA FDA CFDA CE Bone Graft Substitute 1.8 cm 1.8cm Wire-guided Single minimally invasive wound of pedicle screw Bone-filling cage 1.8cm, blood loss less than 100cc, the patient was discharged the next day 13
Slide 14: What is Vertebral Compression Fracture?
What is Vertebral Compression Fracture? The spine vertebral body collapses due to factors such as the external condyles or osteoporosis. In the end, it can cause spinal deformities and severe back pain. Wedge fracture is the most common type of compression fracture, accounting for about 70 ~ 80% The
Slide 15: Development Trend of Vertebral Compression fracture Surgery
Development Trend of Vertebral Compression fracture Surgery Vertebroplasty Kyphoplasty Expandable device + Bone cement Bone cement injection in vertebral Use a balloon to support the collapse The mechanical support is used to open body and exit, and then inject bone cement the collapse and then the
Slide 16: Vertebral Body Augmentation System (Tripod-Fix)
Wiltrom patented technology product-Vertebral Body Augmentation System (Tripod-Fix) TFDA a. Three dimension expansion, effective result for anterior height restoration b. The spreading process is stable c. Rollback mechanism for patient’s safety Cement injection process Expansion process 28.4% Befor
Slide 17: Bone Cement Market
Bone Cement Market Wiltrom Bone Cement Liquid Powder Expected to obtain TFDA 2020 17
Slide 18: Worldwide Competitors
Worldwide Competitors Liquid 18
Slide 19: Outline
Outline Company Profile 1 2 Market Overview 3 Product Competitive Advantage 4 Strategic and Vision 19
Slide 20: Product Portfolio
Product Portfolio Spinal Fixation Surgery Vertebral Compression Bone Cement Frx Surgery ⚫ Bone cement system ⚫ Spinal fixation system ⚫ Vertebral Body (pedicle screw) Augmentation System Liquid ⚫ Interbody fusion system (cage) ⚫ Bone graft substitute Liquid Powder 20
Slide 21: Company Income Statement
Company Income Statement NTD$’000 2015 2016 2017 2018 2019/10 Operation revenue 44,241 55,507 58,112 59,829 54,877 Gross profit 26,100 33,710 33,063 35,073 31,602 Operation expenses 29,838 43,501 52,784 75,259 71,242 Selling expenses 8,144 10,090 7,602 24,851 24,762 General and 11,126 8,329 11,034 1
Slide 22: Growth Engine
Growth Engine After ten years of research and development energy accumulation has erupted, innovative value products will bring a new wave of energy growth in the future 2009 2018 2019 2020 Spinal Fixation Single-incision VBAS(Tripod-Fix) Bone Cement Products spinal fixation Liquid Powder 十年研發能量累積 T
Slide 23: Future potential of innovative value products
Future potential of innovative value products Prospective To The Future Looking for opportunities for technology transfer or cooperation with international company 23
Slide 24: Global markets and sales locations
Global markets and sales locations TAIWAN ⚫ Taiwan Headquater, Biomedical Science Park(2009) ⚫ Wiltrom Inc, San Jose (2018) ⚫ Shanghai Branch(2018) Wiltrom Co., Ltd was established in 2009, and its products are under its own brand Sales in more than 10 countries in the world. Customers in Europe, As
Slide 25: Key market strategy & sales performance
Key market strategy & sales performance - High market mastery, revenue grows year by year - Focus on self-paid markets with product differentiation - More than 20 physician consultants 28% USA China Taiwan Export ratio is - Wiltrom Inc - The world's first minimally invasive - Distributor: Microport
Slide 26: Outline
Outline Company Profile 1 2 Market Overview 3 Product Competitive Advantage 4 Strategic and Vision 26
Slide 27: Future development strategy
Future development strategy R&D perspective Continue to strengthen R & D energy, • Continue to develop market-oriented spine medical accelerate commercialization and speed equipment products to market • Strengthen the innovation and execution of R & D personnel and reduce the risk of product develop
Slide 28: Vision
Vision Continue to start from the unmet clinical needs and develop products with market competitive to become safe and effective providers of innovative spinal solutions. 28 圖片來源: Singapore Biodesign
Slide 29: THANK YOU
THANK YOU 29